MedTrace Logo

Attune With TruMatch TM Personalized Solutions Instruments

NCT02177227 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 194

Last updated 2023-05-31

No results posted yet for this study

Summary

The purpose of our study is to determine, using a prospective, randomized-controlled trial, the economic viability and clinical outcomes associated with patient-specific instrumentation (PSI) for total knee arthroplasty in an obese patient population.

Conditions

Interventions

DEVICE

Attune TruMatch (TM) Patient-Specific Instrumentation

Patients to receive total knee replacement with TruMatch Patient-Specific Instrumentation

Sponsors & Collaborators

  • DePuy Orthopaedics

    collaborator INDUSTRY

  • Johnson & Johnson Medical Companies

    collaborator INDUSTRY

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Edward M Vasarhelyi, MD · London Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02177227 on ClinicalTrials.gov